Clinical results after total talar replacement with alumina ceramic prosthesis evaluated using SAFE-Q for osteonecrosis of the talus.

• Material Type: 博士論文
• Title: Clinical results after total talar replacement with alumina ceramic prosthesis evaluated using SAFE-Q for osteonecrosis of the talus.
• Author/Editor: Miura, Kimio; Taniguchi, Akira; Ueno, Yuki; Morita, Shigeki; Kurokawa, Hiroaki; Tanaka, Yasuhito
• Author Heading: Miura, Kimio; Taniguchi, Akira; Ueno, Yuki; Morita, Shigeki; Kurokawa, Hiroaki; Tanaka, Yasuhito
• Publication, Distribution, etc.: 奈良医学会
• Publication Date: 2022-11-30
• Publication Date (W3CDTF): 2022-11-30
• Alternative Title: 距骨壊死に対するアルミナセラミック性人工距骨置換術のSAFE-Qを用いた臨床成績
• Periodical title: Journal of Nara Medical Association
• No. or year of volume/issue: 73 4,5,6
• Volume: 73
• Issue: 4,5,6
• Pages: 55-63
• ISSN (Periodical Title): ISSN : 1345-0069
• Degree grantor/type: 奈良県立医科大学
• Date Granted: 2022-12-22
• Dissertation Number: 甲第856号
• Degree Type: 博士（医学）
• Text Language Code: eng
• Subject Heading: SAFE-Q; total talar replacement; talar osteonecrosis
• Target Audience: 一般
• Note (General): type:Thesis; Background: The purpose of this retrospective review was to evaluate the clinical outcomes of patients who underwent total talar replacement for talar necrosis using the SAFE-Q score, which was hypothesized to improve postoperatively. Methods: The study included 24 ankles of 22 patients who underwent total talar replacement from 2012 to 2018 and were evaluated using SAFE-Q preoperatively and postoperatively. Statistical analysis was performed using the mean values of the SAFE-Q and JSSF scale scores, and the range of ankle motion was compared before and 3 years after the surgery using the Wilcoxon signed-rank test. Results: The SAFE-Q scores improved postoperatively in the all the subcategories. “Pain and Pain-Related” changed from a mean value of 42.2±23.9 points preoperatively to a mean value of 84.6±12.6 points postoperatively (p<.01); “Physical Functioning and Daily Living” changed from 36.3±25.2 points to 73.4±20.5 points (p<.01); “Social Functioning” changed from 34.1±34.8 points to 81.0±25.3 points (p<.01); “Shoe-Related” changed from 41.3±28.9 points to 75.4±22.3 points (p<.01); “General Health and Well-Being” changed from 36.7±32.1 to 76.9±29.3 points (p<.01). Conclusion: Twenty-four osteonecrotic tali of 22 patients treated with alumina ceramic total talar replacement achieved good clinical results, as evaluated using the JSSF ankle/hindfoot score and SAFE-Q. Alumina ceramic total talar replacement is the mainstream treatment for talar osteonecrosis.; 博士（医学）・甲第856号・令和4年12月22日; identifier:Journal of Nara Medical Association Vol.73 No.4,5,6 p.55-63 (2022.11); identifier:13450069; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/4085; identifier:Journal of Nara Medical Association, 73(4,5,6): 55-63
• Access Restrictions: インターネット公開
• Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• Original Data Provider (Database): 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU

Table of Contents

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4085/1/01%e7%94%b2856%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4085/2/02%e7%94%b2856%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/4085/3/03%e7%94%b2856%e6%9c%ac%e6%96%87..pdf fulltext